Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04158700 |
| Title | A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer |
| Recruitment | Withdrawn |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Eli Lilly and Company |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | FRA | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| CHU de Besancon Hopital Jean Minjoz | Besancon Cedex | 25030 | France | Details | ||
| Gustave Roussy | Villejuif Cedex | 94805 | France | Details | ||
| Institut Catala d'Oncologia | L'Hospitalet de Llobregat | Barcelona | 08907 | Spain | Details | |
| Hospital Clinic I Provincial | Barcelona | 08036 | Spain | Details | ||
| Hospital Madrid Norte Sanchinarro | Madrid | 28050 | Spain | Details |